摘要:
A catalyst composition comprising a polymer functionalized with a ligand for binding a transition metal containing compound to form a transition metal complex, wherein said functionalized polymer has a number average molecular weight of about 5,000 to 30,000 g/mol and a polydispersity index of about 1.0 to 2.0. The catalyst is used in a hydroformylation reaction, preferably one in which the liquid phase has been volumetrically expanded with a compressed gas, is readily recyclable using nanofiltration.
摘要:
A catalyst composition comprising a polymer functionalized with a ligand for binding a transition metal containing compound to form a transition metal complex, wherein said functionalized polymer has a number average molecular weight of about 5,000 to 30,000 g/mol and a polydispersity index of about 1.0 to 2.0. The catalyst is used in a hydroformylation reaction, preferably one in which the liquid phase has been volumetrically expanded with a compressed gas, is readily recyclable using nanofiltration.
摘要:
The present invention relates to compounds of formula (I) with a variety of therapeutic uses, more particularly the substituted cyclic alkylidene compounds are useful for selective estrogen receptor modulation.
摘要:
Systems and techniques relating to channel equalization in received communications signals are described. In one aspect, a communications signal of a channel is obtained and channel effects are removed from the communications signal by generating one or more time-varying channel response estimates.
摘要:
The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
摘要:
The present invention relates to compounds of formula (I) with a variety of therapeutic uses, more particularly the substituted cyclic alkylidene compounds are useful for selective estrogen receptor modulation.
摘要:
Systems, apparatus and methods are provided for detecting the mode of a received OFDM signal. A received signal may be correlated with one or more time-delayed version of itself resulting in a set of correlation signals. Each correlation signal may be analyzed for one or more characteristics that can be used to determine the symbol length of the received signal. In order to minimize the number of correlations performed, one or more correlations can be used with varying symbol lengths and a fixed guard interval length. The correlation signals can be processed by filters, and the characteristics of the filtered correlation signals can be analyzed to determine the guard interval length of the received signal. In addition to detecting symbol length, the present invention can be used to detect receiver impairment and perform any appropriate compensations.
摘要:
The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
摘要:
Apparatus and methods relating to channel equalization include a method including: generating a first output signal in a frequency domain based on a communications signal of a channel; determining a first channel response based on the first output signal and one or more pilot signals of the communications signal; generating a first equalized signal based on the first output signal and the first determined channel response; generating a first decision signal based on the first equalized signal; generating an output signal in a time domain based on the first decision signal; determining a second channel response based on the time domain output signal; generating a second output signal in the frequency domain based on the second channel response; generating a second equalized signal based on the first and second output signals and the time domain output signal; and generating a second decision signal based on the second equalized signal.
摘要:
The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.